Virax Biolabs Group Limited
Virax Biolabs Group Limited (VRAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VRAX · as of Jun 9, 2026
Key Statistics
Explore Virax Biolabs Group Limited Data
vrax stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The VRAX analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing +431.35% upside from the current price of $0.19.
Competitors & Peers
vrax competitorsVRAX
ARTL
ATXI
DRMA
ELAB
GTBPStock Performance
Full HistoryAbout Virax Biolabs Group Limited
Virax Biolabs Group Limited is a biotechnology firm that specializes in the sale, distribution, and promotion of diagnostic testing kits, medical technology, and personal protective equipment (PPE). I…
what is virax biolabs group limited · vrax stock overview · virax biolabs group limited company profile · who is virax biolabs group limited ceo · vrax NASDAQ · virax biolabs group limited headquarters · virax biolabs group limited business segments
About Stock Overview & Key Data
Virax Biolabs Group Limited (VRAX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 21, 2022. As of the latest trading session, VRAX stock price is $0.19, with a market capitalization of $817,156. The stock has returned -81.19% over the past 12 months and -45.05% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Virax Biolabs Group Limited stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, Virax Biolabs Group Limited reported revenue of $6331.00 and net income of -$6.1M. For detailed data — including Virax Biolabs Group Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Virax Biolabs Group Limited (VRAX) stock price is $0.19. The stock is traded on NASDAQ under the ticker symbol VRAX. The 52-week range is $0.10 – $1.14.